Injectable peptides are booming across wellness and biohacking circles, but the science and regulatory oversight are struggling to keep pace, writes Dr Sophia Moscovis.
Biohacking has become one of the loudest corners of the wellness world. I am 51, and as both an industry insider and a professionally curious Gen X woman, I have made it my mission to test what works and call out what does not.
Ovum, founded by Dr Ariella Heffernan-Mark, has raised $1.7 million in a pre-seed round to tackle the women’s health market – projected to be worth $121 billion by 2033. Globally, the gender health gap is valued at $1 trillion.
Forbes Australia Editor-in-Chief Sarah O’Carroll gives a sneak peak on what to expect from Forbes Australia issue #2. On sale now.
Wondermind is casting a wide net and encouraging daily work to achieve “mental fitness.”